Biodesix, Inc. (BDSX)

Biodesix, Inc. (BDSX) is a healthcare company (diagnostics & research) based in the United States. The share price is $8.88, down 1.33% on the day, which values the company at $98.47M. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$8.88−1.33% today
Market value
$98.47M
Funk Score
40/100
200-week average
$22.9061% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Biodesix, Inc. in more detail

BDSX trades at -40.4× next year's expected earnings, 0.9× sales. It sits 61% below its 200-week average of $22.90.

Over the last five fiscal years Biodesix, Inc. has compounded revenue 14.2% a year. Its Funk Score is 40 out of 100 (financial strength 1.7, profitability 2.0, growth 8.5, each out of 10).

In its favour: Operating margin is expanding. Worth checking: Altman Z in the distress zone; Share count keeps rising.

Biodesix, Inc. (BDSX): questions and answers

What is Biodesix, Inc.'s market cap?

Biodesix, Inc. is valued at $98.47M at a share price of $8.88.

Is BDSX above its 200-week moving average?

No. BDSX is 61.2% below its 200-week average of $22.90. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Biodesix, Inc. growing?

Over the last five fiscal years Biodesix, Inc.'s revenue grew 14.2% a year.

Does BDSX pay a dividend?

Biodesix, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Biodesix, Inc. (BDSX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/BDSX

Underlying data: Yahoo Finance; company filings with the SEC.